Sitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC Patients

Condition:   PDAC - Pancreatic Ductal Adenocarcinoma Intervention:   Drug: Combination of sitagliptin+ gemcitabine + nab-paclitaxel Sponsor:   Tianjin Medical University Cancer Institute and Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials